Patents Assigned to Universite Bordeau Segalen
  • Publication number: 20120128789
    Abstract: The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia.
    Type: Application
    Filed: July 13, 2010
    Publication date: May 24, 2012
    Applicants: Universite Bordeau Segalen, L'Air Liquide Societe Anonyme Pour L'Etude Et Exploitation Des Procedes georges Claude
    Inventors: Baptiste Bessiere, Guy Simonnet